Nailfold capillaroscopy abnormalities correlate with cutaneous and visceral involvement in systemic sclerosis patients

Acta Reumatologica Portuguesa

Volumn 34, Issue 2, 2009, Pages 219-227

  Sato, Lucy T ^a   Kayser, Cristiane ^a   Andrade, Luís E C ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Microcirculation; Nailfold capillaroscopy; Raynaud's phenomenon; Systemic sclerosis

Indexed keywords

ADULT; AGED; ANGIOSCOPY; ARTICLE; FEMALE; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; SKIN DISEASE; SYSTEMIC SCLEROSIS; VISCERA;

ADULT; AGED; FEMALE; HUMANS; MALE; MICROSCOPIC ANGIOSCOPY; MIDDLE AGED; RETROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC; SKIN DISEASES; VISCERA; YOUNG ADULT;

EID: 67650188591     PISSN: 0303464X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. LeRoy EC. Systemic Sclerosis. A vascular perspective. Rheum Dis Clin North Am 1996;22:675-694.
2. Campbell PM, LeRoy EC Pathogenesis of systemic sclerosis: a vascular hypothesis. Semin Arthritis Rheum 1975;4:351-368.
3. Dabich L, Bookstein JJ, Zweifler A et al. Digital arteries in patients with scleroderma. Arch Intern Med 1972;130:708-714.
4. Maricq HR, LeRoy EC. Patterns of finger capillary abnormalities in connective tissue disease by "widefield" microscopy. Arthritis Rheum 1973;16:619-628.
5. Maricq KR, LeRoy EC, D'Angelo WA et al. Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum 1980;23:183-189.
6. Andrade LEC, Gabriel Jr. A, Assad RL et al. Panoramic nailfold capillaroscopy: a new reading method and normal range. Semin Arthritis Rheum 1990;20:21-31.
7. Maricq HR. Wide-field capillary microscopy. Arthritis Rheum 1981;24:1159-1165.
8. Cutolo M, Grassi W, Matucci Cerinic M. Raynaud's phenomenon and the role of capillaroscopy. Arthritis Rheum 2003;48:3023-3030.
9. Carpentier P, Franco A, Béani JC et al. Intérêt de la capillaroscopie périunguéale dans le diagnostic précoce de la sclérodermie systémique. Ann Dermatol Venereol 1983;110:11-20.
10. Ganczarczyk ML, Lee P, Armstrong SK. Nailfold capillary microscopy in polymyositis and dermatomyositis. Arthritis Rheum 1988;31:116-119.
11. Maricq HR, Spencer-Green G, LeRoy EC. Skin capillary abnormalities as indicators of organ involvement in scleroderma, Raynaud's syndrome and dermatomyositis. Am J Med 1976;61:862-870.
12. Chen Ze-Y I, Silver RM, Ainsworth SK et al. Association between fluorescent antinuclear antibodies, capillary patterns, and clinical features in scleroderma spectrum disorders. Am J Med 1984;77:817-822.
13. Joyal F, Choquette D, Roussin A et al. Evaluation of the severity of systemic sclerosis by nailfold capillary microscopy in 112 patients. Angiology 1992;43:203-210.
14. Lovy M, MacCarter D, Steigerwald JC. Relationship between nailfold capillary abnormalities and organ involvement in systemic sclerosis. Arthritis Rheum 1985;28:496-501.
15. Bredemeier M, Xavier RM, Capobianco KG et al. Nailfold capillary microscopy can suggest pulmonary disease activity in systemic sclerosis. J Rheumatol 2004;31:286-294.
16. Masi AT, Rodnan GP, Medsger Jr TA et al. Preliminary Criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-590.
17. Seibold JR. Scleroderma. In: Kelley WN, Ruddy S, Harris ED, Sledge CB. Textbook of Rheumatology, 5th ed. WB Saunders, Philadelphia-USA, 1997:1133-1163.
18. Le Roy EC, Black C, Fleischmajer R et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-205.
19. Lee P, Leung F, Alderdice C et al. Nailfold capillary microscopy in the connective tissue diseases: a semiquantitative assessment. J Rheumatology 1983;10: 930-938.
20. Brennan P, Silman A, Black C et al. Reliability of skin involvement measures in scleroderma. The UK Scleroderma Study Group. Br J Rheumatol 1992;31:457-460.
21. Maricq HR, Harper FE, Khan MM. Microvascular abnormalities as possible predictors of disease subsets in Raynaud's phenomenon and early connective tissue disease. Clin Exp Rheum 1983;1:195-205.
22. Priollet P, Vayssairat M, Housset E. How to classify Raynaud,s phenomenon. Long-term follow-up study of 73 cases. Am J Med 1987;83:494-498.
23. Cortes S, Cutolo M. Capillaroscopic patterns in rheumatic diseases. Acta Reumatol Port 2007;32:29-36.
24. Spencer Spencer-Green G. Outcomes in primary Raynaud phenomenon. A meta-analysis of the frequency, rates, and predictors of transition to secondary diseases. Arch Intern Med 1998;158:595-600.
25. Ostojic P, Damjanov N. Different clinical features in patients with limited and diffuse cutaneous systemic sclerosis. Clin Rheumatol 2006;25:453-457.
26. Cutolo M, Sulli A, Pizzorni C et al. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 2000;27:155-160.
27. Houtman PM, Kallenberg CG, Wouda AA et al. Decreased nailfold capillary density in Raynaud's phenomenon: a reflection of immunologically mediated local and systemic vascular disease? Ann Rheum Dis 1985;44:603-609.
28. Statham BN, Rowell NR. Quantification of the nail fold capillary abnormalities in systemic sclerosis and Raynaud's syndrome. Acta Derm Venereol 1986;66:139-143.
29. Giordano M, Valentini G, Migliaresi S et al. Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis. J Rheumatol 1986;13:911-916.
30. Medsger TA Jr, Masi AT. The epidemiology of systemic sclerosis (scleroderma). Ann Intern Med 1971;74:714-721.
31. Ingegnoli F, Gualtierotti R, Lubatti C et al. Feasibility of Different Capillaroscopic Measures for Identifying Nailfold Microvascular Alterations. Semin Arthritis Rheum In Press, Available online, December 2007.